Results 151 to 160 of about 3,668,940 (297)
Analysis of competing risks of cardiovascular death in patients with hepatocellular carcinoma: A population-based study. [PDF]
Cao L +5 more
europepmc +1 more source
Cell‐Based Biohybrid Micro/Nanorobots for Biotherapy
This review systematically evaluates cell‐based biohybrid micro/nanorobots (CB‐BMRs), highlighting their cell selection criteria, fabrication strategies, and diverse actuation modes. Furthermore, it surveys the promising therapeutic applications of CB‐BMRs in targeted cancer, thrombosis, and inflammation treatments, while comprehensively discussing ...
Lin Wang +11 more
wiley +1 more source
Details of cardiovascular death, non-cardiovascular death, and other major adverse cardiovascular events.
Takashi Ogane (16542172) +4 more
core +1 more source
Flexible surgical robots are advancing minimally invasive interventions for cardiovascular diseases and cancer by enabling precise navigation through complex, submillimeter anatomical pathways. This review highlights recent innovations in actuation, bio‐integrated sensing, AI‐assisted control, and friction‐reduction technologies, discusses current ...
Hermione Truong +14 more
wiley +1 more source
GDF-15 at admission predicts cardiovascular death, heart failure, and bleeding outcomes in patients with CAD. [PDF]
Wang J +15 more
europepmc +1 more source
Mechanical stress activates BAP31 in chondrocytes. BAP31 competes with ATG14 for binding to STX17, disrupting the STX17–ATG14 complex required for autophagosome–lysosome fusion. The resultant autophagic flux blockade drives the generation of autophagy‐derived exosomes, which mediate pathological cartilage calcification in OA. Chondrocyte‐targeted BAP31
Zhi‐hua Xu +13 more
wiley +1 more source
Predicting cardiovascular death in overweight/obese people with prediabetes using machine learning-a proof-of-concept study. [PDF]
Andersen AK +6 more
europepmc +1 more source
The influence of atrial high-rate episodes on stroke and cardiovascular death: an update. [PDF]
Toennis T +17 more
europepmc +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
Allostatic Load of Glucose Homeostasis, Epigenetic Biomarkers, and All-Cause and Cardiovascular Death: A Prospective Cohort Study. [PDF]
Hong L +12 more
europepmc +1 more source

